An investigation on behalf of investors in CEL-SCI Corporation (NYSE:CVM) shares over potential wrongdoing at CEL-SCI Corporation was announced.

San Diego, CA -- (SBWire) -- 09/07/2021 --Certain directors of CEL-SCI Corporation are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of CEL-SCI Corporation (NYSE: CVM) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain CEL-SCI directors breached their fiduciary duties and caused damage to the company and its shareholders.

Vienna, VA based CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and other diseases.

CEL-SCI Corporation reported that its Net Loss increased from $22.13 million for the 12 months period that ended on September 30, 2019 to $30.25 million for the 12 months period that ended on September 30, 2020.

On June 28, 2021, CEL-SCI Corporation announced that the Phase 3 study for the Company's Multikine (leukocyte interleukin) immunotherapy candidate missed its primary endpoint for primary (previously untreated) squamous cell carcinoma of the head and neck.

Shares of CEL-SCI Corporation (NYSE: CVM) declined from $27.28 per share June 28, 201 to as low as $7.08 per share on July 2, 2021.

Those who purchased shares of CEL-SCI Corporation (NYSE: CVM), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.